1 Schwab RE, Froidevaux S, Paku S, et al.Antiproliferative ef-ficacy of the somatostatin analogue TT-232 in human melanoma cells and tumours[J]. Anticancer Res, 2001;21:71-5
2 Liu D, Martino G, Thangaraju M, et al.Caspase-8-mediated intracellular acidification precedes mitochondrial dysfunction in somatostatin-induced apoptosis[J]. J Biol Chem, 2000;275: 9244-50
3 Stewart PM, James RA.The future of somatostatin analogue therapy[J]. Baillieres Best Pract Res Clin Endocrinol Metab, 1999;13:409-18
4 Patel YC.Somatostatin and its receptor family[J]. Front Neu-roendocrinol, 1999;20:157-98
5 Srikant CB.Cell cycle dependent induction of apoptosis by so-matostatin analog SMS201-995 in AtT-20 mouse pituitary cells [J]. Biochem Biophys Res Commun, 1995;209:400-6
6 Thompson JS.Somatostatin analogue predisposes enterocytes to apoptosis[J]. JGastrointest Surg, 1998;2:167-73
7 Virgolini I.New trends in peptide receptor radioligands[J]. J Nucl Med AlliedSci, 2001;45:153-9
8 吴佩, 芮景, 夏祥厚, 等.大肠癌胃泌素、生长抑素的表达及其比势研究[J]. 中华实验外科杂志, 1998;15:520-1
9 Buscail L, Saint-Laurent N, Chastre E, et al.Loss of sst2 so-matostatin receptor gene expression in human pancreatic and col-orectal cancer[J]. Cancer Res, 1996;56:1823-7
10 Reubi JC, Horisberger U, Laissue J.High density of somato-statin receptors in veins surrounding human cancer tissue:role in tumor-host interaction[J] ?Int J Cancer, 1994;56:681-8
11 Sharma K, Patel YC, Srikant CB.C-terminal region of human somatostatin receptor 5 is required for induction of Rb and G 1 cell cycle arrest[J]. Mol Endocrinol, 1999;13:82-90
12 Thangaraju M, Sharma K, Leber B, et al.Regulation of acidi-fication and apoptosis by SHP-1 and Bcl -2[J]. J Biol Chem, 1999;274:29549-57
13 何双梧, 赵言明, 沈康强.生长抑素对人结肠癌裸鼠移植瘤的作用及机理[J]. 中国普外基础与临床杂志, 1999;6:1-3
14 Szegedi Z, Takacs J, Szende B, et al.A specifically radiola-beled somatostatin analog with strong antitumor activity induces apoptosis and accumulates in the cytosol and the nucleus of HT29 human colon carcinoma cells[J]. Endocrine, 1999;10: 25-34
15 Melen-Mucha G, Winczyk K, Pawlikowski M.Somatostatin analogue octreotide and melatonin inhibit bromodeoxyuridine in-corporation into cell nuclei and enhance apoptosis in the trans-plantable murine colon 38 cancer[J]. Anticancer Res, 1998; 18:3615-9
16 Ferjoux G, BousquetC, Cordelier P, et al.Signal transduction of somatostatin receptors negatively controlling cell proliferation [J]. J Physiol Paris, 2000;94:205-10
17 Hocker M, Wiedenmann B.Therapeutic and diagnostic impli-cations of the somatostatin system in gastroenteropancreatic neu-roendocrine tumour disease[J]. Ital J Gastroenterol Hepatol, 1999;31Suppl 2:S139-42
18 Pollak MN, Schally AV.Mechanisms of antineoplastic action of somatostatin analogs[J]. Proc Soc Exp Biol Med, 1998;217: 143-52
19 Larsson LI.Developmental biology of gastrin and somatostatin cells in the antropyloricmucosa of the stomach[J]. Microsc Res Tech, 2000;48:272-81
20 Cao BH, Mortensen K, Tornehave D, et al.Apoptosis in rat gastric antrum:evidence that regulation by food intake depends on nitric oxide synthase[J]. J Histochem Cytochem, 2000;48: 123-31
21 Thompson JS.Epidermal growth factor inhibits somatostatin-in-duced apoptosis[J]. J Surg Res, 1999;81:95-100
22 Boros LG, Lee PW, Brandes JL, et al.Inhibition of the oxida-tive and nonoxidative pentose phosphate pathways by somato-statin:a possible mechanism of antitumor action[J]. Med Hy-potheses, 1998;50:501-6
23 Szende B, Srkalovic G, Schally AV, et al.Inhibitory effectsof analogs of luteinizing hormone-releasing hormone and somato-statin on pancreatic cancersin hamsters.Events that accompany tumor regression[J]. Cancer, 1990;65:2279-90
24 Szende B, Lapis K, Redding TW, et al.Growth inhibition of MXT mammary carcinoma by enhancing programmed cell death (apoptosis) with analogs of LH-RH and somatostatin[J]. Breast Cancer Res Treat, 1989;14:307-14
25 Zalatnai A, Pogany V.Somatostatin analogs in the treatment of pancreatic cancer:utopia or feasible alternative[J] ?Orv Hetil, 2000;141:2333-8
26 Eriksson B, Oberg K.Summing up 15 years of somatostatin analog therapy in neuroendocrine tumors:future outlook[J]. Ann Oncol, 1999;10 Suppl 2:S31-8
27 Imam H, Eriksson B, Lukinius A, et al.Induction of apopto-sis in neuroendocrine tumors of the digestive system during treatment with somatostatin analogs[J]. Acta Oncol, 1997;36: 607-14
28 Keri G, Erchegyi J, Horvath A, et al.A tumor-selective so-matostatin analog (TT-232) with strong in vitro and in vivo anti-tumor activity[J]. Proc Natl Acad Sci U S A, 1996;93:12513-8
29 Saitoh Y, Arita N, Ohnishi T, et al.Absence of apoptosis in somatotropinomas treated with octreotide[J]. Acta Neurochir (Wien), 1997;139:851-6 |
